70 related articles for article (PubMed ID: 34853102)
1. ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19.
McCafferty K; Hollowood Z; Allen M; Lockhart D; Chorlton J; Martin J
BMJ Open; 2021 Dec; 11(12):e049650. PubMed ID: 34853102
[TBL] [Abstract][Full Text] [Related]
2. A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation.
Chorlton J; Hollowood Z; Dyer C; Lockhart D; Boekman P; McCafferty K; Coffey P; Marelli-Berg F; Martin J
EClinicalMedicine; 2022 Sep; 51():101604. PubMed ID: 35996565
[TBL] [Abstract][Full Text] [Related]
3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
4. Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus.
Kiyosue A; Hayashi N; Komori H; Leonsson-Zachrisson M; Johnsson E
Diabetes Obes Metab; 2013 Oct; 15(10):923-30. PubMed ID: 23522182
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform.
Gaughan E; Quinn T; Bruce A; Antonelli J; Young V; Mair J; Akram A; Hirani N; Koch O; Mackintosh C; Norrie J; Dear JW; Dhaliwal K
BMJ Open; 2021 Dec; 11(12):e054442. PubMed ID: 34911721
[TBL] [Abstract][Full Text] [Related]
6. Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.
Wilmot EG; Evans M; Barnard-Kelly K; Burns M; Cranston I; Elliott RA; Gkountouras G; Kanumilli N; Krishan A; Kotonya C; Lumley S; Narendran P; Neupane S; Rayman G; Sutton C; Taxiarchi VP; Thabit H; Leelarathna L
BMJ Open; 2021 Jul; 11(7):e050713. PubMed ID: 34261691
[TBL] [Abstract][Full Text] [Related]
7. Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protocol for a randomised, double-blind, placebo controlled clinical trial.
Legacy M; Seely D; Conte E; Psihogios A; Ramsay T; Fergusson DA; Kanji S; Simmons JG; Wilson K
BMJ Open; 2022 Mar; 12(3):e057024. PubMed ID: 35241474
[TBL] [Abstract][Full Text] [Related]
8. PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.
Mollerup A; Larsen SC; Bennetzen AS; Henriksen M; Simonsen MK; Weis N; Kofod LM; Heitmann BL
BMJ Open; 2021 Jun; 11(6):e050582. PubMed ID: 34193503
[TBL] [Abstract][Full Text] [Related]
9. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
Veenith T; Fisher BA; Slade D; Rowe A; Sharpe R; Thickett DR; Whitehouse T; Rowland M; Scriven J; Parekh D; Bowden SJ; Savage JS; Richards D; Bion J; Kearns P; Gates S; ;
BMJ Open; 2021 Nov; 11(11):e050202. PubMed ID: 34764169
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
[TBL] [Abstract][Full Text] [Related]
11. ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.
Kotsaki A; Pickkers P; Bauer M; Calandra T; Lupse M; Wiersinga WJ; Meylan S; Bloos F; van der Poll T; Slim MA; van Mourik N; Müller MCA; van Vught L; Vlaar APJ; de Nooijer A; Bakkerus L; Weis S; Antonakos N; Netea MG; Giamarellos-Bourboulis EJ
BMJ Open; 2022 Dec; 12(12):e067251. PubMed ID: 36600424
[TBL] [Abstract][Full Text] [Related]
12. EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35-50 kg/m
Patel P; Thomas R; Hamady M; Hague J; Raja J; Tan T; Bloom S; Richards T; Weiss CR; Prechtl CG; Smith C; Sasikaran T; Hesketh R; Bourmpaki E; Johnson NA; Fiorentino F; Ahmed AR
BMJ Open; 2023 Sep; 13(9):e072327. PubMed ID: 37770263
[TBL] [Abstract][Full Text] [Related]
13. Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data.
Vasileiou E; Shi T; Kerr S; Robertson C; Joy M; Tsang R; McGagh D; Williams J; Hobbs R; de Lusignan S; Bradley D; OReilly D; Murphy S; Chuter A; Beggs J; Ford D; Orton C; Akbari A; Bedston S; Davies G; Griffiths LJ; Griffiths R; Lowthian E; Lyons J; Lyons RA; North L; Perry M; Torabi F; Pickett J; McMenamin J; McCowan C; Agrawal U; Wood R; Stock SJ; Moore E; Henery P; Simpson CR; Sheikh A
BMJ Open; 2022 Feb; 12(2):e050062. PubMed ID: 35165107
[TBL] [Abstract][Full Text] [Related]
14. Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial.
Lovre D; Bateman K; Sherman M; Fonseca VA; Lefante J; Mauvais-Jarvis F
BMJ Open; 2021 Nov; 11(11):e053684. PubMed ID: 34848523
[TBL] [Abstract][Full Text] [Related]
15. COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.
Richards DA; Sugg HV; Cockcroft E; Cooper J; Cruickshank S; Doris F; Hulme C; Logan P; Iles-Smith H; Melendez-Torres GJ; Rafferty AM; Reed N; Russell AM; Shepherd M; Singh SJ; Thompson Coon J; Tooze S; Wootton S; Abbott R; Bethel A; Creanor S; Quinn L; Tripp H; Warren FC; Whear R; Bollen J; Hunt HA; Kent M; Morgan L; Morley N; Romanczuk L
BMJ Open; 2021 May; 11(5):e046436. PubMed ID: 34039574
[TBL] [Abstract][Full Text] [Related]
16. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.
Tang H; Bohannon L; Lew M; Jensen D; Jung SH; Zhao A; Sung AD; Wischmeyer PE
BMJ Open; 2021 May; 11(5):e047069. PubMed ID: 33952552
[TBL] [Abstract][Full Text] [Related]
17. Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT).
Pal A; Stapleton S; Yap C; Lai-Kwon J; Daly R; Magkos D; Baikady BR; Minchom A; Banerji U; De Bono J; Karikios D; Boyle F; Lopez J
BMJ Open; 2021 Sep; 11(9):e049217. PubMed ID: 34489282
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS).
Bailey M; Linden D; Earley O; Guo Parke H; McAuley DF; Peto T; Taggart C; Kidney J
BMJ Open; 2023 Nov; 13(11):e074726. PubMed ID: 38035747
[TBL] [Abstract][Full Text] [Related]
19. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study.
Mueller T; Kerr S; McTaggart S; Kurdi A; Vasileiou E; Docherty A; Fraser K; Shi T; Simpson CR; Bennie M; Sheikh A
BMJ Open; 2021 Nov; 11(11):e054861. PubMed ID: 34799365
[TBL] [Abstract][Full Text] [Related]
20. United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.
Teece L; Gray LJ; Melbourne C; Orton C; Ford DV; Martin CA; McAllister D; Khunti K; Tobin M; John C; Abrams KR; Pareek M;
BMJ Open; 2021 Jun; 11(6):e046392. PubMed ID: 34183342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
